Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons.
The neurotoxin, DSP-4, (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride) specifically and significantly reduces norepinephrine (NE) and its metabolite, 3-methoxy-4-hydroxyphenylethylene glycol (MHPG), in cortical, hippocampal and cerebellar brain regions. Pretreatment with the selective monoamine oxidase (MAO) B inhibitor, deprenyl, and the non-specific MAO inhibitor, pargyline, effectively blocked NE depletion. Pretreatment with the selective MAO A inhibitor, clorgyline, had no effect on central NE DSP-4 toxicity. Thus formation of a toxic metabolite by the action of MAO B may be involved in DSP-4 induced neural damage.